칼스메드(CARL)는 NAS에 상장된 Healthcare · Health Information Services 기업입니다. 현재가 $15.58 (+1.24%), 시가총액 $267.50M.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
칼스메드의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.
칼스메드의 현재 주가는 $15.58 (+1.24%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.
칼스메드의 시가총액은 약 $267.50M입니다.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions.